Directory
>
Bei Yu Md
Bei Yu Md
Vp, Drug Safety & Pharmacovigilance | Blueprint Medicines
Cambridge, Massachusetts, United States
Bei Yu Md
Summary
Dr. Bei Yu is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President of Drug Safety and Pharmacovigilance at Blueprint Medicines. With a robust background in biotechnology and regulatory affairs, she has held pivotal roles at renowned companies such as Biogen and Sanofi Genzyme. Dr. Yu is recognized for her expertise in managing safety and risk assessments in drug development, particularly in oncology. Her leadership experience spans over several years, during which she has contributed significantly to advancing drug safety protocols. An advocate for innovation in drug safety, she is committed to enhancing patient outcomes through rigorous pharmacovigilance practices. Despite her busy professional life, she remains passionate about mentoring emerging leaders in the field. Dr. Yu's international perspective adds a unique dimension to her role, as she navigates complex regulatory landscapes across different markets.
Bei Yu Md
Work Experience
Vp, Drug Safety & Pharmacovigilance at
Blueprint Medicines
January 2020 - Present
Medical Director, Global Safety Officer, Safety, Benefit And Risk Management at
Biogen
July 2014 - Present
Senior Medical Director, Drug Safety And Pharmacovigilance at
Blueprint Medicines
Senior Medical Director, Drug Safety at
Alkermes
Medical Director, Global Safety Officer, Global Pharmacovigilance And Epidemiology at
Sanofi Genzyme
Frequently Asked Questions about Bei Yu Md
What is Bei Yu Md email address?
Bei Yu Md's primary email address is ***@amagpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Bei Yu Md work for?
Bei Yu Md is a Vp, Drug Safety & Pharmacovigilance at Blueprint Medicines, a company specializing in Commercial physical research.
How can I directly contact Bei Yu Md?
To contact Bei Yu Md directly, you can use the email address ***@amagpharma.com. Complete contact information is available upon registration with Muraena.
Who is Bei Yu Md?
Dr. Bei Yu is a seasoned executive in the pharmaceutical industry, currently serving as the Vice President of Drug Safety and Pharmacovigilance at Blueprint Medicines. With a robust background in biotechnology and regulatory affairs, she has held pivotal roles at renowned companies such as Biogen and Sanofi Genzyme. Dr. Yu is recognized for her expertise in managing safety and risk assessments in drug development, particularly in oncology. Her leadership experience spans over several years, during which she has contributed significantly to advancing drug safety protocols. An advocate for innovation in drug safety, she is committed to enhancing patient outcomes through rigorous pharmacovigilance practices. Despite her busy professional life, she remains passionate about mentoring emerging leaders in the field. Dr. Yu's international perspective adds a unique dimension to her role, as she navigates complex regulatory landscapes across different markets.
Bei`s contact details
***@amagpharma.com
***@blueprintmedicines.com
******@biogen.com
Colleagues
Senior Vice President
Vice President, Head of Discovery Biology
Senior Vice President, Strategic Operations
Senior Vice President, Information Systems
Chief Commercial Officer
Director
SVP, Finance and Accounting
Vice President, Tax & Treasury
Chief Medical Officer
Vice President and General Manager Region Italy, Iberia, France and Benelux at Blueprint Medicines